X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
rheumatoid arthritis (22) 22
humans (15) 15
rheumatology (13) 13
middle aged (9) 9
arthritis (8) 8
dmards (7) 7
female (7) 7
male (7) 7
patients (7) 7
studies (7) 7
antirheumatic agents - therapeutic use (6) 6
arthritis, rheumatoid - drug therapy (6) 6
double-blind (6) 6
medicine, research & experimental (6) 6
rheumatic diseases (6) 6
tumor necrosis factor-tnf (6) 6
american-college (5) 5
clinical medicine (5) 5
etanercept (5) 5
medicine (5) 5
risk (5) 5
tnf inhibitors (5) 5
adult (4) 4
aged (4) 4
ankylosing spondylitis (4) 4
biotechnology & applied microbiology (4) 4
care and treatment (4) 4
epidemiology (4) 4
immunology (4) 4
mortality (4) 4
pharmacology & pharmacy (4) 4
physicians (4) 4
treatment (4) 4
abridged index medicus (3) 3
anti-tnf (3) 3
arthritis, rheumatoid - immunology (3) 3
arthritis, rheumatoid - therapy (3) 3
biological therapies (3) 3
biological therapy (3) 3
calculating (3) 3
classification criteria (3) 3
collaboration (3) 3
computing (3) 3
counting (3) 3
disease (3) 3
efficacy (3) 3
handling record carriers (3) 3
inadequate response (3) 3
inflammatory diseases (3) 3
joint diseases (3) 3
management (3) 3
medical personnel (3) 3
modifying antirheumatic drugs (3) 3
physics (3) 3
presentation of data (3) 3
public health (3) 3
recognition of data (3) 3
record carriers (3) 3
remission (3) 3
research (3) 3
retention (3) 3
rheumatoid factor (3) 3
sensors (3) 3
time factors (3) 3
tocilizumab (3) 3
treatment outcome (3) 3
1506 (2) 2
616.7: krankheiten des bewegungsapparates und orthopädie (2) 2
[ sdv.mhep.rsoa ] life sciences [q-bio]/human health and pathology/rhumatology and musculoskeletal system (2) 2
abatacept (2) 2
accelerometers (2) 2
acoustics (2) 2
adalimumab (2) 2
adherence (2) 2
adolescent (2) 2
adsorption (2) 2
age (2) 2
aging (2) 2
analysis (2) 2
ankylosing-spondylitis (2) 2
antinuclear antibodies (2) 2
arthritis, rheumatoid - economics (2) 2
arthritis, rheumatoid - epidemiology (2) 2
biochemistry, genetics and molecular biology (2) 2
biologic therapy (2) 2
biological products (2) 2
biosimilar (2) 2
complications and side effects (2) 2
cost of illness (2) 2
criteria (2) 2
cytokines (2) 2
damage (2) 2
data processing (2) 2
databases, factual (2) 2
decision-making (2) 2
diagnosis (2) 2
disability (2) 2
disease-activity (2) 2
drug dosages (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Rheumatology, ISSN 1462-0324, 03/2019, Volume 58, Issue Supplement_2
Journal Article
Journal Article
Biologics: Targets and Therapy, ISSN 1177-5475, 01/2015, Volume 9, pp. 1 - 6
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2017, Volume 76, Issue 3, pp. 491 - 496
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2011, Volume 70, Issue 11, pp. 1999 - 2002
Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 1/2020, p. annrheumdis-2019-216655
ObjectivesTo provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most... 
DMARDs (biologic) | treatment | DMARDs (synthetic) | Immunology | Rheumatology | economic evaluations | Biochemistry, Genetics and Molecular Biology(all) | rheumatoid arthritis | Immunology and Allergy
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 08/2014, Volume 10, Issue 8, pp. 1049 - 1057
Biologic therapies, predominantly TNF-α inhibitors, have revolutionized the treatment of rheumatoid arthritis (RA). However, their clinical utility can be... 
TNF antagonists | biologic therapies | abatacept | etanercept | infliximab | rheumatoid arthritis | adalimumab | antidrug antibodies | immunogenicity | rituximab | INFLAMMATORY DISEASES | INADEQUATE RESPONSE | MONOCLONAL-ANTIBODY | IMMUNOLOGY | ANTITUMOR NECROSIS FACTOR | LONG-TERM SAFETY | DOUBLE-BLIND | ADALIMUMAB ANTIBODIES | INFLIXIMAB ANTIBODIES | CLINICAL-RESPONSE
Journal Article
The European Journal of Health Economics, ISSN 1618-7598, 5/2014, Volume 15, Issue S1, pp. S35 - S43
Journal Article